Andrew Perry

Insider Reports History

Location
Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Perry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $0 $2.51 18 Sep 2024 Direct
G1 Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 0 18 Sep 2024 Direct

Insider Reports Filed by Andrew Perry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GTHX G1 Therapeutics, Inc. 18 Sep 2024 5 $0 4 Chief Commercial Officer 18 Sep 2024, 16:15
GTHX G1 Therapeutics, Inc. 05 Jul 2024 1 -$3.35K 4 Chief Commercial Officer 08 Jul 2024, 17:59
GTHX G1 Therapeutics, Inc. 01 Jul 2024 1 $0 4 Chief Commercial Officer 03 Jul 2024, 17:34
GTHX G1 Therapeutics, Inc. 13 May 2024 1 -$39K 4 Chief Commercial Officer 15 May 2024, 16:12
GTHX G1 Therapeutics, Inc. 03 Jan 2024 4 -$7.53K 4 Chief Commercial Officer 08 Jan 2024, 06:03
GTHX G1 Therapeutics, Inc. 05 Jul 2023 1 -$871 4 Chief Commercial Officer 07 Jul 2023, 16:08
GTHX G1 Therapeutics, Inc. 10 May 2023 1 $0 4 Chief Commercial Officer 12 May 2023, 16:19
GTHX G1 Therapeutics, Inc. 03 Jan 2023 3 -$4.57K 4 Chief Commercial Officer 05 Jan 2023, 19:25
GTHX G1 Therapeutics, Inc. 03 Jan 2022 2 $0 4 Chief Commercial Officer 05 Jan 2022, 19:25
GTHX G1 Therapeutics, Inc. 16 Aug 2021 1 $0 4 Chief Commercial Officer 17 Aug 2021, 16:53
GTHX G1 Therapeutics, Inc. 16 Aug 2021 0 $0 3 Chief Commercial Officer 17 Aug 2021, 16:53